FOLDAX®
Foldax® Closes $20 Million Financing
MemorialCare Innovation Fund led the round, with Angel Physicians Fund and Sayan Bioventures joining as new investors.
FOLDAX®
Enrollment in Tria LifePolymer™ Early Feasibility Study Completed
Fifteen patients have been enrolled in the Tria LifePolymer early feasibility study reports FOLDAX.
FOLDAX®
Foldax Tria LifePolymer™ Heart Valve Technology Honored with The Best Innovation Award at CRT 2020
Tria LifePolymer heart valves are made with LifePolymer, a novel, patented biopolymer developed specifically for heart valve application.
